Back
Cocrystal Pharma Vs. Cara Therapeutics Industry Stock Comparison
Buy
62
COCP
Cocrystal Pharma
Last Price:
1.87
Seasonality Move:
10.39%
Sell
39
CARA
Cara Therapeutics
Last Price:
0.28
Seasonality Move:
5.28%
Buy
62
Cocrystal Pharma (COCP)
is a Buy
Is Cocrystal Pharma a Buy, Sell or Hold?
- The current Cocrystal Pharma [COCP] share price is $1.86. The Score for COCP is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- COCP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Cara Therapeutics (CARA)
is a Sell
Is Cara Therapeutics a Buy, Sell or Hold?
- The current Cara Therapeutics [CARA] share price is $0.29. The Score for CARA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- CARA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
COCP Stock Price Chart
What is Cocrystal Pharma's stock price today?
-
The Cocrystal Pharma share price today is $1.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COCP is experiencing slight buying pressure.
CARA Stock Price Chart
What is Cara Therapeutics's stock price today?
-
The Cara Therapeutics share price today is $0.29
The current trend is relatively stagnant and CARA is experiencing slight selling pressure.
COCP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 50.15 | Buy |
| Chaikin Money Flow: | 9044 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.71 - 1.99) | Buy |
| Bollinger Bands (100): | (1.7 - 2.28) | Sell |
CARA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 54.71 | Buy |
| Chaikin Money Flow: | -14865 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.25 - 0.29) | Buy |
| Bollinger Bands (100): | (0.26 - 0.36) | Sell |
COCP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.83 | Buy |
| 20-day SMA: | 1.88 | Sell |
| 50-day SMA: | 1.8 | Buy |
| 200-day SMA: | 1.83 | Buy |
| 8-day EMA: | 1.84 | Buy |
| 20-day EMA: | 1.85 | Buy |
| 50-day EMA: | 1.86 | Buy |
| 200-day EMA: | 1.93 | Sell |
CARA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.28 | Buy |
| 20-day SMA: | 0.27 | Buy |
| 50-day SMA: | 0.29 | Sell |
| 200-day SMA: | 0.53 | Sell |
| 8-day EMA: | 0.29 | Buy |
| 20-day EMA: | 0.28 | Buy |
| 50-day EMA: | 0.3 | Sell |
| 200-day EMA: | 0.75 | Sell |
Cocrystal Pharma Earnings Growth & COCP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.27 per share.
Cara Therapeutics Earnings Growth & CARA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.50 per share.
Cocrystal Pharma Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cara Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||